Cytomegalovirus Retinitis Completed Phase Trials for Ganciclovir (DB01004)

Also known as: CMV retinitis / Cytomegaloviral retinitis (disorder) / Cytomegalovirus chorioretinitis / Chorioretinitis caused by Cytomegalovirus (disorder)

IndicationStatusPhase
DBCOND0000283 (Cytomegalovirus Retinitis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002330A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSTreatment
NCT00002257A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDSTreatment
NCT00002299The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSTreatment
NCT00002247A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir TherapyTreatment
NCT00002134A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus RetinitisTreatment
NCT00002135An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous AccessTreatment
NCT00002025Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised PatientTreatment
NCT00002015An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in ChildrenTreatment
NCT00002034A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDSTreatment
NCT00001999A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDSTreatment
NCT00000989The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDSTreatment
NCT00000665Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir ComponentTreatment